Skip to content
naulon
Not checkedNot checked for notices yet.

THE DROPLET DIGITAL PCR: A NEW VALID MOLECULAR APPROACH FOR THE ASSESSMENT OF BRAFV600E MUTATION IN HAIRY CELL LEUKEMIA.

Francesca Guerrini, Matteo Paolicchi, Francesco Ghio and 14 more

Frontiers in Pharmacology · 2016

doi:10.3389/fphar.2016.00363 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Hairy cell leukemia (HCL) is a chronic lymphoproliferative B-cell disorder where the B-RAF V600E mutation has been recently detected, as reported for solid neoplasias but not for other B-cell lymphomas. The digital droplet PCR (dd-PCR) is a molecular technique that, without standard references, is able to accurately quantitate DNA mutations. ddPCR could be an useful instrument for the detection of the B-RAFV600E mutation in HCL, where the minimal residual disease monitoring is fundamental for planning a patients-targeted treatment in the era of new anti-CD20 and anti-RAF compounds.This retrospective study enrolled 47 patients observed at the Hematology Unit of the University of Pisa, Italy, from January 2005 to January 2014: 27 patients were affected by classic HCL, two by the variant HCL (vHCL), and 18 by splenic marginal zone lymphoma (SMZL). The aim of the study was to compare dd-PCR to classic quantitative PCR (QT-PCR) in terms of sensitivity and specificity and to demonstrate its possible use in HCL. Results showed that: 1) the sensitivity of dd-PCR is about half a logarithm superior to QT-PCR (5x10-5 versus 2.5x10-4); 2) the specificity of the dd-PCR is comparable to QT-PCR (no patient with marginal splenic lymphoma or HCL variant resulted mutated); 3) its high sensitivity would allow to use dd-PCR in the monitoring of MRD. At the end of treatment, among patients in complete remission, 33% were still MRD-positive by dd-PCR versus 28% by QT-PCR versus 11% by the evaluation of the B-cell clonality; after 12 months, dd-PCR was comparable to QT-PCR and both detected the B-RAF mutation in 15% of cases defined as MRD-negative by IgH rearrangement. Moreover, 4) the feasibility and the costs of dd-PCR are comparable to those of QT-PCR.In conclusion, our study supports the introduction of dd-PCR in the scenario of HCL, also during the follow-up.

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.